PremiumCompany AnnouncementsCyclacel Pharmaceuticals Delays 10-K Filing CYCC Upcoming Earnings Report: What to Expect? Cyclacel announces $1M private placement of convertible preferred stock PremiumCompany AnnouncementsCyclacel Pharmaceuticals Reports Q3 2024 Financial Results Biotech Alert: Searches spiking for these stocks today CYCC Earnings Report this Week: Is It a Buy, Ahead of Earnings? PremiumThe FlyCyclacel Pharmaceuticals downgraded to Neutral from Buy at Roth MKM Cyclacel reports clinical data from Phase 2 study of oral fadraciclib Biotech Alert: Searches spiking for these stocks today